Zobrazeno 1 - 10
of 541
pro vyhledávání: '"myelodysplastic syndrome (MDS)"'
Autor:
Sakditad Saowapa, Natchaya Polpichai, Manasawee Tanariyakul, Thanathip Suenghataiphorn, Narathorn Kulthamrongsri, Maireigh McCullough, Mariana Goncalves Damasceno Moreira, Pharit Siladech, Lukman Tijani
Publikováno v:
Hemato, Vol 5, Iss 2, Pp 208-219 (2024)
Background: Autoimmune disorders (ADs) are prevalent among patients with myelodysplastic syndrome (MDS), yet their impact on MDS outcomes, including overall survival (OS), mortality, and transformation to acute myeloid leukemia (AML), is not well def
Externí odkaz:
https://doaj.org/article/caf72f6cfce3483f9dc535d13360fb08
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
Although the involvement of glycan structures in diseases has long been recognized, their detailed and high-throughput investigation has only recently been made possible due to technological advancements. For this reason, glycosylation is a generally
Externí odkaz:
https://doaj.org/article/f89846b58b844d87a675276b1b42b307
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-7 (2023)
Abstract Anemia is the most common manifestation in myelodysplastic syndrome (MDS) patients, but the cause of ineffective hematopoiesis is not fully understood. Enucleation is an important event in the maturation process of erythroblasts. According t
Externí odkaz:
https://doaj.org/article/fa8a643804df425eae238080a1bc0166
Autor:
Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Midori Ishii, Yoko Azusawa, Yasuharu Hamano, Hidetaka Eguchi, Masami Arai, Jun Ando, Miki Ando
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24801- (2024)
Background: Acute graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with significant morbidity and mortality, and efficacy of currently available therapeutics are limited. Acute
Externí odkaz:
https://doaj.org/article/2568fad0772844d3aee047e5688cdf1f
Autor:
Paola Montes, Iryna Rusanova, Elena Cornejo, Paloma García, Ana Guerra-Librero, Mª del Señor López, Tomás de Haro, Germaine Escames, Darío Acuña-Castroviejo
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6784 (2024)
Etiological factors involved in myelodysplastic syndrome (MDS) include immunologic, oxidative stress and inflammatory factors, among others, and these are targets for microRNAs (miRNs). Here, we evaluated whether some miRNs may affect tumor developme
Externí odkaz:
https://doaj.org/article/4675d19eb4d64a4ba8bc0e2028fdcacc
Autor:
Matthew Poynton, Catriona Gilmour-Hamilton, Isabella Dale-Harris, Evelyn Clarke, Simon Stanworth, Mike Murphy, Noémi Roy
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundWithout a definitive curative option available to many patients, learning to live with myelodysplastic syndrome (MDS) and manage symptoms effectively becomes a priority in their care. Anaemia is an almost universal feature of MDS. Individua
Externí odkaz:
https://doaj.org/article/ba90b6f0f3af4633b2140cca1d9736c5
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
The correct maintenance and differentiation of hematopoietic stem cells (HSC) in bone marrow is vital for the maintenance and operation of the human blood system. GATA2 plays a critical role in the maintenance of HSCs and the specification of HSCs in
Externí odkaz:
https://doaj.org/article/07dfc3c98ca747a7af51e22802af1e1d
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e19222- (2023)
Myelodysplastic syndrome (MDS) is a hematological malignancy of undetermined etiology, possibly linked to chromosomal structural alterations, genetic mutations, presentation and carcinogenicity of variant antigens on cell surface, and the generation
Externí odkaz:
https://doaj.org/article/c81cf3cb593f49b08e8ccdd7bf63f487
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 301-313 (2022)
Abstract The natural history of patients with myelodysplastic syndrome (MDS) is dependent upon the presence and magnitude of diverse genetic and molecular aberrations. The International Prognostic Scoring System (IPSS) and revised IPSS (IPSS‐R) are
Externí odkaz:
https://doaj.org/article/2648363954a243749afc7c304250dcc5